{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:39:55Z","timestamp":1762504795047},"reference-count":154,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2001,7,1]],"date-time":"2001-07-01T00:00:00Z","timestamp":993945600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2001,7,1]],"date-time":"2001-07-01T00:00:00Z","timestamp":993945600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2001,7,1]]},"DOI":"10.1038\/sj.leu.2402169","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T21:05:45Z","timestamp":1032469545000},"page":"1022-1032","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":152,"title":["The kiss of death: promises and failures of death receptors and ligands in cancer therapy"],"prefix":"10.1038","volume":"15","author":[{"given":"PT","family":"Daniel","sequence":"first","affiliation":[]},{"given":"T","family":"Wieder","sequence":"additional","affiliation":[]},{"given":"I","family":"Sturm","sequence":"additional","affiliation":[]},{"given":"K","family":"Schulze-Osthoff","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2001,7,19]]},"reference":[{"key":"BF2402169_CR1","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1046\/j.1432-1327.1998.2540439.x","volume":"254","author":"K Schulze-Osthoff","year":"1998","unstructured":"Schulze-Osthoff K, Ferrari D, Los M, Wesselborg S, Peter ME . Apoptosis signaling by death receptors Eur J Biochem 1998 254: 439\u2013459","journal-title":"Eur J Biochem"},{"key":"BF2402169_CR2","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1056\/NEJM199611283352204","volume":"335","author":"J Drappa","year":"1996","unstructured":"Drappa J, Vaishnaw AK, Sullivan KE, Chu JL, Elkon KB . Fas gene mutations in the Canale\u2013Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity N Engl J Med 1996 335: 1643\u20131649","journal-title":"N Engl J Med"},{"key":"BF2402169_CR3","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1073\/pnas.96.8.4552","volume":"96","author":"DA Martin","year":"1999","unstructured":"Martin DA, Zheng L, Siegel RM, Huang B, Fisher GH, Wang J, Jackson CE, Puck JM, Dale J, Straus SE, Peter ME, Krammer PH, Fesik S, Lenardo MJ . Defective CD95\/APO-1\/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia Proc Natl Acad Sci USA 1999 96: 4552\u20134557","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF2402169_CR4","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/00008480-199912000-00009","volume":"11","author":"CE Jackson","year":"1999","unstructured":"Jackson CE, Puck JM . Autoimmune lymphoproliferative syndrome, a disorder of apoptosis Curr Opin Pediatr 1999 11: 521\u2013527","journal-title":"Curr Opin Pediatr"},{"key":"BF2402169_CR5","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1172\/JCI5121","volume":"103","author":"AK Vaishnaw","year":"1999","unstructured":"Vaishnaw AK, Orlinick JR, Chu JL, Krammer PH, Chao MV, Elkon KB . The molecular basis for apoptotic defects in patients with CD95 (Fas\/Apo-1) mutations J Clin Invest 1999 103: 355\u2013363","journal-title":"J Clin Invest"},{"key":"BF2402169_CR6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0092-8674(00)80605-4","volume":"98","author":"J Wang","year":"1999","unstructured":"Wang J, Zheng L, Lobito A, Chan FK, Dale J, Sneller M, Yao X, Puck JM, Straus SE, Lenardo MJ . Inherited human caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II Cell 1999 98: 47\u201358","journal-title":"Cell"},{"key":"BF2402169_CR7","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1182\/blood.V95.10.3176","volume":"95","author":"U Ramenghi","year":"2000","unstructured":"Ramenghi U, Bonissoni S, Migliaretti G, DeFranco S, Bottarel F, Gambaruto C, DiFranco D, Priori R, Conti F, Dianzani I, Valesini G, Merletti F, Dianzani U . Deficiency of the Fas apoptosis pathway without Fas gene mutations is a familial trait predisposing to development of autoimmune diseases and cancer Blood 2000 95: 3176\u20133182","journal-title":"Blood"},{"key":"BF2402169_CR8","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/sj.bmt.1701306","volume":"22","author":"BJ Sleight","year":"1998","unstructured":"Sleight BJ, Prasad VS, DeLaat C, Steele P, Ballard E, Arceci RJ, Sidman CL . Correction of autoimmune lymphoproliferative syndrome by bone marrow transplantation Bone Marrow Transplant 1998 22: 375\u2013380","journal-title":"Bone Marrow Transplant"},{"key":"BF2402169_CR9","first-page":"965 (Abstr.)","volume":"14","author":"M Freedman","year":"2000","unstructured":"Freedman M, Dror Y . Shwachman\u2013Diamond syndrome: aberrant hematopoeitic progenitors, faulty marrow microenvironment, inherited MDS\/AML and Fas-mediated apoptosis Leukemia 2000 14: 965 (Abstr.)","journal-title":"Leukemia"},{"key":"BF2402169_CR10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/sj.leu.2401233","volume":"13","author":"P Gupta","year":"1999","unstructured":"Gupta P, Niehans GA, LeRoy SC, Gupta K, Morrison VA, Schultz C, Knapp DJ, Kratzke RA . Fas ligand expression in the bone marrow in myelodysplastic syndromes correlates with FAB subtype and anemia, and predicts survival Leukemia 1999 13: 44\u201353","journal-title":"Leukemia"},{"key":"BF2402169_CR11","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1038\/sj.leu.2401979","volume":"14","author":"M Blagosklonny","year":"2000","unstructured":"Blagosklonny M . The dilemma of apoptosis in myelodysplasia and leukemia: a new promise of therapeutic intervention? Leukemia 2000 14: 2017\u20132018","journal-title":"Leukemia"},{"key":"BF2402169_CR12","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1038\/sj.leu.2401538","volume":"13","author":"P Tsoplou","year":"1999","unstructured":"Tsoplou P, Kouraklis-Symeonidis A, Thanopoulou E, Zikos P, Orphanos V, Zoumbos NC . Apoptosis in patients with myelodysplastic syndromes: differential involvement of marrow cells in \u2018good\u2019 vs \u2018poor\u2019 prognosis patients and correlation with apoptosis-related genes Leukemia 1999 13: 1554\u20131563","journal-title":"Leukemia"},{"key":"BF2402169_CR13","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/ijc.2910580419","volume":"58","author":"LR Coney","year":"1994","unstructured":"Coney LR, Daniel PT, Sanborn D, Dhein J, Debatin KM, Krammer PH, Zurawski VR Jr . Apoptotic cell death induced by a mouse-human anti-APO-1 chimeric antibody leads to tumor regression Int J Cancer 1994 58: 562\u2013567","journal-title":"Int J Cancer"},{"key":"BF2402169_CR14","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.4049\/jimmunol.149.10.3166","volume":"149","author":"J Dhein","year":"1992","unstructured":"Dhein J, Daniel PT, Trauth BC, Oehm A, Moller P, Krammer PH . Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens J Immunol 1992 149: 3166\u20133173","journal-title":"J Immunol"},{"key":"BF2402169_CR15","first-page":"1825","volume":"8","author":"KM Lucking-Famira","year":"1994","unstructured":"Lucking-Famira KM, Daniel PT, Moller P, Krammer PH, Debatin KM . APO-1 (CD95) mediated apoptosis in human T-ALL engrafted in SCID mice Leukemia 1994 8: 1825\u20131833","journal-title":"Leukemia"},{"key":"BF2402169_CR16","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/364806a0","volume":"364","author":"J Ogasawara","year":"1993","unstructured":"Ogasawara J, Watanabe-Fukunaga R, Adachi M, Matsuzawa A, Kasugai T, Kitamura Y, Itoh N, Suda T, Nagata S . Lethal effect of the anti-Fas antibody in mice Nature 1993 364: 806\u2013809","journal-title":"Nature"},{"key":"BF2402169_CR17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1172\/JCI6926","volume":"104","author":"A Ashkenazi","year":"1999","unstructured":"Ashkenazi A, Pai RC, Fong S, Leung S, Lawrence DA, Marsters SA, Blackie C, Chang L, McMurtrey AE, Hebert A, DeForge L, Koumenis IL, Lewis D, Harris L, Bussiere J, Koeppen H, Shahrokh Z, Schwall RH . Safety and antitumor activity of recombinant soluble Apo2 ligand J Clin Invest 1999 104: 155\u2013162","journal-title":"J Clin Invest"},{"key":"BF2402169_CR18","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/5517","volume":"5","author":"H Walczak","year":"1999","unstructured":"Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, Kubin M, Chin W, Jones J, Woodward A, Le T, Smith C, Smolak P, Goodwin RG, Rauch CT, Schuh JC, Lynch DH . Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo Nat Med 1999 5: 157\u2013163","journal-title":"Nat Med"},{"key":"BF2402169_CR19","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0952-7915(94)90102-3","volume":"6","author":"PH Krammer","year":"1994","unstructured":"Krammer PH, Behrmann I, Daniel P, Dhein J, Debatin KM . Regulation of apoptosis in the immune system Curr Opin Immunol 1994 6: 279\u2013289","journal-title":"Curr Opin Immunol"},{"key":"BF2402169_CR20","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/35037728","volume":"407","author":"PH Krammer","year":"2000","unstructured":"Krammer PH . CD95\u2019s deadly mission in the immune system Nature 2000 407: 789\u2013795","journal-title":"Nature"},{"key":"BF2402169_CR21","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0092-8674(00)81874-7","volume":"88","author":"S Nagata","year":"1997","unstructured":"Nagata S . Apoptosis by death factor Cell 1997 88: 355\u2013365","journal-title":"Cell"},{"key":"BF2402169_CR22","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1146\/annurev.immunol.17.1.331","volume":"17","author":"D Wallach","year":"1999","unstructured":"Wallach D, Varfolomeev EE, Malinin NL, Goltsev YV, Kovalenko AV, Boldin MP . Tumor necrosis factor receptor and Fas signaling mechanisms Annu Rev Immunol 1999 17: 331\u2013367","journal-title":"Annu Rev Immunol"},{"key":"BF2402169_CR23","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S1074-7613(00)80244-7","volume":"6","author":"JL Bodmer","year":"1997","unstructured":"Bodmer JL, Burns K, Schneider P, Hofmann K, Steiner V, Thome M, Bornand T, Hahne M, Schroter M, Becker K, Wilson A, French LE, Browning JL, MacDonald HR, Tschopp J . TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1\/CD95) Immunity 1997 6: 79\u201388","journal-title":"Immunity"},{"key":"BF2402169_CR24","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1126\/science.274.5289.990","volume":"274","author":"AM Chinnaiyan","year":"1996","unstructured":"Chinnaiyan AM, O'Rourke K, Yu GL, Lyons RH, Garg M, Duan DR, Xing L, Gentz R, Ni J, Dixit VM . Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95 Science 1996 274: 990\u2013992","journal-title":"Science"},{"key":"BF2402169_CR25","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/384372a0","volume":"384","author":"J Kitson","year":"1996","unstructured":"Kitson J, Raven T, Jiang YP, Goeddel DV, Giles KM, Pun KT, Grinham CJ, Brown R, Farrow SN . A death-domain-containing receptor that mediates apoptosis Nature 1996 384: 372\u2013375","journal-title":"Nature"},{"key":"BF2402169_CR26","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/S0960-9822(02)70791-4","volume":"6","author":"SA Marsters","year":"1996","unstructured":"Marsters SA, Sheridan JP, Donahue CJ, Pitti RM, Gray CL, Goddard AD, Bauer KD, Ashkenazi A . Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-kappa B Curr Biol 1996 6: 1669\u20131676","journal-title":"Curr Biol"},{"key":"BF2402169_CR27","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0014-5793(98)00791-1","volume":"431","author":"G Pan","year":"1998","unstructured":"Pan G, Bauer JH, Haridas V, Wang S, Liu D, Yu G, Vincenz C, Aggarwal BB, Ni J, Dixit VM . Identification and functional characterization of DR6, a novel death domain-containing TNF receptor FEBS Lett 1998 431: 351\u2013356","journal-title":"FEBS Lett"},{"key":"BF2402169_CR28","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0014-5793(98)00135-5","volume":"424","author":"G Pan","year":"1998","unstructured":"Pan G, Ni J, Yu G, Wei YF, Dixit VM . TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signalling FEBS Lett 1998 424: 41\u201345","journal-title":"FEBS Lett"},{"key":"BF2402169_CR29","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1126\/science.277.5327.815","volume":"277","author":"G Pan","year":"1997","unstructured":"Pan G, Ni J, Wei YF, Yu G, Gentz R, Dixit VM . An antagonist decoy receptor and a death domain-containing receptor for TRAIL Science 1997 277: 815\u2013818","journal-title":"Science"},{"key":"BF2402169_CR30","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1126\/science.276.5309.111","volume":"276","author":"G Pan","year":"1997","unstructured":"Pan G, O'Rourke K, Chinnaiyan AM, Gentz R, Ebner R, Ni J, Dixit VM . The receptor for the cytotoxic ligand TRAIL Science 1997 276: 111\u2013113","journal-title":"Science"},{"key":"BF2402169_CR31","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S1074-7613(00)80401-X","volume":"7","author":"P Schneider","year":"1997","unstructured":"Schneider P, Thome M, Burns K, Bodmer JL, Hofmann K, Kataoka T, Holler N, Tschopp J . TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB Immunity 1997 7: 831\u2013836","journal-title":"Immunity"},{"key":"BF2402169_CR32","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0014-5793(97)01231-3","volume":"416","author":"P Schneider","year":"1997","unstructured":"Schneider P, Bodmer JL, Thome M, Hofmann K, Holler N, Tschopp J . Characterization of two receptors for TRAIL FEBS Lett 1997 416: 329\u2013334","journal-title":"FEBS Lett"},{"key":"BF2402169_CR33","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1126\/science.277.5327.818","volume":"277","author":"JP Sheridan","year":"1997","unstructured":"Sheridan JP, Marsters SA, Pitti RM, Gurney A, Skubatch M, Baldwin D, Ramakrishnan L, Gray CL, Baker K, Wood WI, Goddard AD, Godowski P, Ashkenazi A . Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors Science 1997 277: 818\u2013821","journal-title":"Science"},{"key":"BF2402169_CR34","doi-asserted-by":"publisher","first-page":"5386","DOI":"10.1093\/emboj\/16.17.5386","volume":"16","author":"H Walczak","year":"1997","unstructured":"Walczak H, Degli-Esposti MA, Johnson RS, Smolak PJ, Waugh JY, Boiani N, Timour MS, Gerhart MJ, Schooley KA, Smith CA, Goodwin RG, Rauch CT . TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL EMBO J 1997 16: 5386\u20135397","journal-title":"EMBO J"},{"key":"BF2402169_CR35","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1084\/jem.186.7.1165","volume":"186","author":"MA Degli-Esposti","year":"1997","unstructured":"Degli-Esposti MA, Smolak PJ, Walczak H, Waugh J, Huang CP, DuBose RF, Goodwin RG, Smith CA . Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family J Exp Med 1997 186: 1165\u20131170","journal-title":"J Exp Med"},{"key":"BF2402169_CR36","doi-asserted-by":"crossref","first-page":"14363","DOI":"10.1074\/jbc.273.23.14363","volume":"273","author":"JG Emery","year":"1998","unstructured":"Emery JG, McDonnell P, Burke MB, Deen KC, Lyn S, Silverman C, Dul E, Appelbaum ER, Eichman C, DiPrinzio R, Dodds RA, James IE, Rosenberg M, Lee JC, Young PR . Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL J Biol Chem 1998 273: 14363\u201314367","journal-title":"J Biol Chem"},{"key":"BF2402169_CR37","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/S0960-9822(06)00422-2","volume":"7","author":"SA Marsters","year":"1997","unstructured":"Marsters SA, Sheridan JP, Pitti RM, Huang A, Skubatch M, Baldwin D, Yuan J, Gurney A, Goddard AD, Godowski P, Ashkenazi A . A novel receptor for Apo2L\/TRAIL contains a truncated death domain Curr Biol 1997 7: 1003\u20131006","journal-title":"Curr Biol"},{"key":"BF2402169_CR38","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","volume":"89","author":"WS Simonet","year":"1997","unstructured":"Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Boyle WJ . Osteoprotegerin: a novel secreted protein involved in the regulation of bone density Cell 1997 89: 309\u2013319","journal-title":"Cell"},{"key":"BF2402169_CR39","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1083\/jcb.145.3.527","volume":"145","author":"TL Burgess","year":"1999","unstructured":"Burgess TL, Qian Y, Kaufman S, Ring BD, Van G, Capparelli C, Kelley M, Hsu H, Boyle WJ, Dunstan CR, Hu S, Lacey DL . The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts J Cell Biol 1999 145: 527\u2013538","journal-title":"J Cell Biol"},{"key":"BF2402169_CR40","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1084\/jem.189.7.1017","volume":"189","author":"EA Green","year":"1999","unstructured":"Green EA, Flavell RA . TRANCE-RANK, a new signal pathway involved in lymphocyte development and T cell activation J Exp Med 1999 189: 1017\u20131020","journal-title":"J Exp Med"},{"key":"BF2402169_CR41","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1126\/science.289.5484.1504","volume":"289","author":"SL Teitelbaum","year":"2000","unstructured":"Teitelbaum SL . Bone resorption by osteoclasts Science 2000 289: 1504\u20131508","journal-title":"Science"},{"key":"BF2402169_CR42","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/25387","volume":"396","author":"RM Pitti","year":"1998","unstructured":"Pitti RM, Marsters SA, Lawrence DA, Roy M, Kischkel FC, Dowd P, Huang A, Donahue CJ, Sherwood SW, Baldwin DT, Godowski PJ, Wood WI, Gurney AL, Hillan KJ, Cohen RL, Goddard AD, Botstein D, Ashkenazi A . Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer Nature 1998 396: 699\u2013703","journal-title":"Nature"},{"key":"BF2402169_CR43","doi-asserted-by":"crossref","first-page":"13733","DOI":"10.1074\/jbc.274.20.13733","volume":"274","author":"KY Yu","year":"1999","unstructured":"Yu KY, Kwon B, Ni J, Zhai Y, Ebner R, Kwon BS . A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis J Biol Chem 1999 274: 13733\u201313736","journal-title":"J Biol Chem"},{"key":"BF2402169_CR44","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1126\/science.8171316","volume":"264","author":"B Beutler","year":"1994","unstructured":"Beutler B, van Huffel C . Unraveling function in the TNF ligand and receptor families Science 1994 264: 667\u2013668","journal-title":"Science"},{"key":"BF2402169_CR45","doi-asserted-by":"crossref","first-page":"32401","DOI":"10.1074\/jbc.272.51.32401","volume":"272","author":"Y Chicheportiche","year":"1997","unstructured":"Chicheportiche Y, Bourdon PR, Xu H, Hsu YM, Scott H, Hession C, Garcia I, Browning JL . TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis J Biol Chem 1997 272: 32401\u201332410","journal-title":"J Biol Chem"},{"key":"BF2402169_CR46","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/1074-7613(95)90057-8","volume":"3","author":"SR Wiley","year":"1995","unstructured":"Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, Sutherland GR, Smith TD, Rauch C, Smith CA . Identification and characterization of a new member of the TNF family that induces apoptosis Immunity 1995 3: 673\u2013682","journal-title":"Immunity"},{"key":"BF2402169_CR47","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0092-8674(93)90132-A","volume":"73","author":"DW Banner","year":"1993","unstructured":"Banner DW, D'Arcy A, Janes W, Gentz R, Schoenfeld HJ, Broger C, Loetscher H, Lesslauer W . Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation Cell 1993 73: 431\u2013445","journal-title":"Cell"},{"key":"BF2402169_CR48","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/384638a0","volume":"384","author":"B Huang","year":"1996","unstructured":"Huang B, Eberstadt M, Olejniczak ET, Meadows RP, Fesik SW . NMR structure and mutagenesis of the Fas (APO-1\/CD95) death domain Nature 1996 384: 638\u2013641","journal-title":"Nature"},{"key":"BF2402169_CR49","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0014-5793(95)00534-G","volume":"367","author":"MP Boldin","year":"1995","unstructured":"Boldin MP, Mett IL, Wallach D . A protein related to a proteasomal subunit binds to the intracellular domain of the p55 TNF receptor upstream to its \u2018death domain\u2019 FEBS Lett 1995 367: 39\u201344","journal-title":"FEBS Lett"},{"key":"BF2402169_CR50","doi-asserted-by":"crossref","first-page":"7795","DOI":"10.1074\/jbc.270.14.7795","volume":"270","author":"MP Boldin","year":"1995","unstructured":"Boldin MP, Varfolomeev EE, Pancer Z, Mett IL, Camonis JH, Wallach D . A novel protein that interacts with the death domain of Fas\/APO1 contains a sequence motif related to the death domain J Biol Chem 1995 270: 7795\u20137798","journal-title":"J Biol Chem"},{"key":"BF2402169_CR51","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/0092-8674(95)90071-3","volume":"81","author":"AM Chinnaiyan","year":"1995","unstructured":"Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM . FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis Cell 1995 81: 505\u2013512","journal-title":"Cell"},{"key":"BF2402169_CR52","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0092-8674(00)80984-8","volume":"84","author":"H Hsu","year":"1996","unstructured":"Hsu H, Shu HB, Pan MG, Goeddel DV . TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways Cell 1996 84: 299\u2013308","journal-title":"Cell"},{"key":"BF2402169_CR53","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1074-7613(00)80252-6","volume":"4","author":"H Hsu","year":"1996","unstructured":"Hsu H, Huang J, Shu HB, Baichwal V, Goeddel DV . TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex Immunity 1996 4: 387\u2013396","journal-title":"Immunity"},{"key":"BF2402169_CR54","doi-asserted-by":"crossref","first-page":"6189","DOI":"10.1002\/j.1460-2075.1996.tb01007.x","volume":"15","author":"AT Ting","year":"1996","unstructured":"Ting AT, Pimentel-Muinos FX, Seed B . RIP mediates tumor necrosis factor receptor 1 activation of NF-kappaB but not Fas\/APO-1-initiated apoptosis EMBO J 1996 15: 6189\u20136196","journal-title":"EMBO J"},{"key":"BF2402169_CR55","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1002\/j.1460-2075.1995.tb00245.x","volume":"14","author":"FC Kischkel","year":"1995","unstructured":"Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, Krammer PH, Peter ME . Cytotoxicity-dependent APO-1 (Fas\/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor EMBO J 1995 14: 5579\u20135588","journal-title":"EMBO J"},{"key":"BF2402169_CR56","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0092-8674(00)81266-0","volume":"85","author":"M Muzio","year":"1996","unstructured":"Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME, Dixit VM . FLICE, a novel FADD-homologous ICE\/CED-3-like protease, is recruited to the CD95 (Fas\/APO-1) death-inducing signaling complex Cell 1996 85: 817\u2013827","journal-title":"Cell"},{"key":"BF2402169_CR57","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0092-8674(00)81334-3","volume":"87","author":"ES Alnemri","year":"1996","unstructured":"Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong WW, Yuan J . Human ICE\/CED-3 protease nomenclature Cell 1996 87: 171","journal-title":"Cell"},{"key":"BF2402169_CR58","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/35008667","volume":"2","author":"JL Bodmer","year":"2000","unstructured":"Bodmer JL, Holler N, Reynard S, Vinciguerra P, Schneider P, Juo P, Blenis J, Tschopp J . TRAIL receptor-2 signals apoptosis through FADD and caspase-8 Nat Cell Biol 2000 2: 241\u2013243","journal-title":"Nat Cell Biol"},{"key":"BF2402169_CR59","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S1074-7613(00)80212-5","volume":"12","author":"FC Kischkel","year":"2000","unstructured":"Kischkel FC, Lawrence DA, Chuntharapai A, Schow P, Kim KJ, Ashkenazi A . Apo2L\/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5 Immunity 2000 12: 611\u2013620","journal-title":"Immunity"},{"key":"BF2402169_CR60","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S1074-7613(00)80211-3","volume":"12","author":"MR Sprick","year":"2000","unstructured":"Sprick MR, Weigand MA, Rieser E, Rauch CT, Juo P, Blenis J, Krammer PH, Walczak H . FADD\/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2 Immunity 2000 12: 599\u2013609","journal-title":"Immunity"},{"key":"BF2402169_CR61","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/385086a0","volume":"385","author":"H Duan","year":"1997","unstructured":"Duan H, Dixit VM . RAIDD is a new \u2018death\u2019 adaptor molecule Nature 1997 385: 86\u201389","journal-title":"Nature"},{"key":"BF2402169_CR62","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1101\/gad.12.9.1304","volume":"12","author":"L Bergeron","year":"1998","unstructured":"Bergeron L, Perez GI, Macdonald G, Shi L, Sun Y, Jurisicova A, Varmuza S, Latham KE, Flaws JA, Salter JC, Hara H, Moskowitz MA, Li E, Greenberg A, Tilly JL, Yuan J . Defects in regulation of apoptosis in caspase-2-deficient mice Genes Dev 1998 12: 1304\u20131314","journal-title":"Genes Dev"},{"key":"BF2402169_CR63","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0092-8674(00)80294-9","volume":"89","author":"X Yang","year":"1997","unstructured":"Yang X, Khosravi-Far R, Chang HY, Baltimore D . Daxx, a novel Fas-binding protein that activates JNK and apoptosis Cell 1997 89: 1067\u20131076","journal-title":"Cell"},{"key":"BF2402169_CR64","doi-asserted-by":"crossref","first-page":"6037","DOI":"10.1093\/emboj\/18.21.6037","volume":"18","author":"S Torii","year":"1999","unstructured":"Torii S, Egan DA, Evans RA, Reed JC . Human Daxx regulates Fas-induced apoptosis from nuclear PML oncogenic domains (PODs) EMBO J 1999 18: 6037\u20136049","journal-title":"EMBO J"},{"key":"BF2402169_CR65","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.4049\/jimmunol.165.3.1337","volume":"165","author":"A Villunger","year":"2000","unstructured":"Villunger A, Huang DC, Holler N, Tschopp J, Strasser A . Fas ligand-induced c-Jun kinase activation in lymphoid cells requires extensive receptor aggregation but is independent of DAXX, and Fas-mediated cell death does not involve DAXX, RIP, or RAIDD J Immunol 2000 165: 1337\u20131343","journal-title":"J Immunol"},{"key":"BF2402169_CR66","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1126\/science.281.5381.1322","volume":"281","author":"JM Adams","year":"1998","unstructured":"Adams JM, Cory S . The Bcl-2 protein family: arbiters of cell survival Science 1998 281: 1322\u20131326","journal-title":"Science"},{"key":"BF2402169_CR67","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1038\/sj.leu.2401940","volume":"14","author":"PT Daniel","year":"2000","unstructured":"Daniel PT . Dissecting the pathways to death Leukemia 2000 14: 2035\u20132044","journal-title":"Leukemia"},{"key":"BF2402169_CR68","doi-asserted-by":"crossref","first-page":"E209","DOI":"10.1038\/70237","volume":"1","author":"MG Van der Heiden","year":"1999","unstructured":"Van der Heiden MG, Thompson CB . Bcl-2 proteins: regulators of apoptosis or of mitochondrial homeostasis? Nat Cell Biol 1999 1: E209\u2013E216","journal-title":"Nat Cell Biol"},{"key":"BF2402169_CR69","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0092-8674(00)80501-2","volume":"90","author":"H Zou","year":"1997","unstructured":"Zou H, Henzel WJ, Liu X, Lutschg A, Wang X . Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3 Cell 1997 90: 405\u2013413","journal-title":"Cell"},{"key":"BF2402169_CR70","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0092-8674(00)80434-1","volume":"91","author":"P Li","year":"1997","unstructured":"Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X . Cytochrome c and dATP-dependent formation of Apaf-1\/Caspase-9 complex initiates an apoptotic protease cascade Cell 1997 91: 479\u2013489","journal-title":"Cell"},{"key":"BF2402169_CR71","doi-asserted-by":"crossref","first-page":"21629","DOI":"10.1074\/jbc.271.35.21629","volume":"271","author":"A Krippner","year":"1996","unstructured":"Krippner A, Matsuno-Yagi A, Gottlieb RA, Babior BM . Loss of function of cytochrome c in Jurkat cells undergoing fas-mediated apoptosis J Biol Chem 1996 271: 21629\u201321636","journal-title":"J Biol Chem"},{"key":"BF2402169_CR72","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1083\/jcb.144.5.891","volume":"144","author":"S Desagher","year":"1999","unstructured":"Desagher S, Osen-Sand A, Nichols A, Eskes R, Montessuit S, Lauper S, Maundrell K, Antonsson B, Martinou J . Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis J Cell Biol 1999 144: 891\u2013901","journal-title":"J Cell Biol"},{"key":"BF2402169_CR73","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1128\/MCB.20.3.929-935.2000","volume":"20","author":"R Eskes","year":"2000","unstructured":"Eskes R, Desagher S, Antonsson B, Martinou JC . Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane Mol Cell Biol 2000 20: 929\u2013935","journal-title":"Mol Cell Biol"},{"key":"BF2402169_CR74","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1038\/sj.leu.2401871","volume":"14","author":"B Fadeel","year":"2000","unstructured":"Fadeel B, Orrenius S, Zhivotovsky B . The most unkindest cut of all: on the multiple roles of mammalian caspases Leukemia 2000 14: 1514\u20131525","journal-title":"Leukemia"},{"key":"BF2402169_CR75","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0092-8674(94)90303-4","volume":"78","author":"NP Walker","year":"1994","unstructured":"Walker NP, Talanian RV, Brady KD, Dang LC, Bump NJ, Ferenz CR, Franklin S, Ghayur T, Hackett MC, Hammill LD . Crystal structure of the cysteine protease interleukin-1 beta-converting enzyme: a (p20\/p10)2 homodimer Cell 1994 78: 343\u2013352","journal-title":"Cell"},{"key":"BF2402169_CR76","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/nsb0796-619","volume":"3","author":"J Rotonda","year":"1996","unstructured":"Rotonda J, Nicholson DW, Fazil KM, Gallant M, Gareau Y, Labelle M, Peterson EP, Rasper DM, Ruel R, Vaillancourt JP, Thornberry NA, Becker JW . The three-dimensional structure of apopain\/CPP32, a key mediator of apoptosis Nat Struct Biol 1996 3: 619\u2013625","journal-title":"Nat Struct Biol"},{"key":"BF2402169_CR77","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0092-8674(00)80434-1","volume":"91","author":"P Li","year":"1997","unstructured":"Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X . Cytochrome c and dATP-dependent formation of Apaf-1\/caspase-9 complex initiates an apoptotic protease cascade Cell 1997 91: 479\u2013489","journal-title":"Cell"},{"key":"BF2402169_CR78","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/sj.cdd.4400451","volume":"5","author":"C Stroh","year":"1998","unstructured":"Stroh C, Schulze-Osthoff K . Death by a thousand cuts: an ever increasing list of caspase substrates Cell Death Differ 1998 5: 997\u20131000","journal-title":"Cell Death Differ"},{"key":"BF2402169_CR79","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0014-5793(97)00717-5","volume":"411","author":"T Wieder","year":"1997","unstructured":"Wieder T, Geilen CC, Kolter T, Sadeghlar F, Sandhoff K, Brossmer R, Ihrig P, Perry D, Orfanos CE, Hannun YA . Bcl-2 antagonizes apoptotic cell death induced by two new ceramide analogues FEBS Lett 1997 411: 260\u2013264","journal-title":"FEBS Lett"},{"key":"BF2402169_CR80","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1083\/jcb.143.5.1353","volume":"143","author":"A Kawahara","year":"1998","unstructured":"Kawahara A, Ohsawa Y, Matsumura H, Uchiyama Y, Nagata S . Caspase-independent cell killing by Fas-associated protein with death domain J Cell Biol 1998 143: 1353\u20131360","journal-title":"J Cell Biol"},{"key":"BF2402169_CR81","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1002\/j.1460-2075.1994.tb06780.x","volume":"13","author":"K Schulze-Osthoff","year":"1994","unstructured":"Schulze-Osthoff K, Krammer PH, Droge W . Divergent signalling via APO-1\/Fas and the TNF receptor, two homologous molecules involved in physiological cell death EMBO J 1994 13: 4587\u20134596","journal-title":"EMBO J"},{"key":"BF2402169_CR82","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1084\/jem.187.9.1477","volume":"187","author":"D Vercammen","year":"1998","unstructured":"Vercammen D, Beyaert R, Denecker G, Goossens V, Van Loo G, Declercq W, Grooten J, Fiers W, Vandenabeele P . Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor J Exp Med 1998 187: 1477\u20131485","journal-title":"J Exp Med"},{"key":"BF2402169_CR83","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1038\/sj.leu.2401864","volume":"14","author":"MV Blagosklonny","year":"2000","unstructured":"Blagosklonny MV . Cell death beyond apoptosis Leukemia 2000 14: 1502\u20131508","journal-title":"Leukemia"},{"key":"BF2402169_CR84","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1084\/jem.192.4.571","volume":"192","author":"SA Susin","year":"2000","unstructured":"Susin SA, Daugas E, Ravagnan L, Samejima K, Zamzami N, Loeffler M, Costantini P, Ferri KF, Irinopoulou T, Prevost MC, Brothers G, Mak TW, Penninger J, Earnshaw WC, Kroemer G . Two distinct pathways leading to nuclear apoptosis J Exp Med 2000 192: 571\u2013580","journal-title":"J Exp Med"},{"key":"BF2402169_CR85","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/17135","volume":"397","author":"SA Susin","year":"1999","unstructured":"Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler M, Larochette N, Goodlett DR, Aebersold R, Siderovski DP, Penninger JM, Kroemer G . Molecular characterization of mitochondrial apoptosis-inducing factor Nature 1999 397: 441\u2013446","journal-title":"Nature"},{"key":"BF2402169_CR86","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1182\/blood.V96.3.1030","volume":"96","author":"C Dumont","year":"2000","unstructured":"Dumont C, Durrbach A, Bidere N, Rouleau M, Kroemer G, Bernard G, Hirsch F, Charpentier B, Susin SA, Senik A . Caspase-independent commitment phase to apoptosis in activated blood T lymphocytes: reversibility at low apoptotic insult Blood 2000 96: 1030\u20131038","journal-title":"Blood"},{"key":"BF2402169_CR87","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/47513","volume":"403","author":"T Nakagawa","year":"2000","unstructured":"Nakagawa T, Zhu H, Morishima N, Li E, Xu J, Yankner BA, Yuan J . Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta Nature 2000 403: 98\u2013103","journal-title":"Nature"},{"key":"BF2402169_CR88","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1126\/science.281.5381.1305","volume":"281","author":"A Ashkenazi","year":"1998","unstructured":"Ashkenazi A, Dixit VM . Death receptors: signaling and modulation Science 1998 281: 1305\u20131308","journal-title":"Science"},{"key":"BF2402169_CR89","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1126\/science.281.5381.1309","volume":"281","author":"DR Green","year":"1998","unstructured":"Green DR, Reed JC . Mitochondria and apoptosis Science 1998 281: 1309\u20131312","journal-title":"Science"},{"key":"BF2402169_CR90","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/74994","volume":"6","author":"G Kroemer","year":"2000","unstructured":"Kroemer G, Reed JC . Mitochondrial control of cell death Nat Med 2000 6: 513\u2013519","journal-title":"Nat Med"},{"key":"BF2402169_CR91","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0092-8674(00)81590-1","volume":"94","author":"H Li","year":"1998","unstructured":"Li H, Zhu H, Xu CJ, Yuan J . Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis Cell 1998 94: 491\u2013501","journal-title":"Cell"},{"key":"BF2402169_CR92","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1083\/jcb.144.2.281","volume":"144","author":"EA Slee","year":"1999","unstructured":"Slee EA, Harte MT, Kluck RM, Wolf BB, Casiano CA, Newmeyer DD, Wang HG, Reed JC, Nicholson DW, Alnemri ES, Green DR, Martin SJ . Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner J Cell Biol 1999 144: 281\u2013292","journal-title":"J Cell Biol"},{"key":"BF2402169_CR93","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1182\/blood.V97.5.1378","volume":"97","author":"T Wieder","year":"2001","unstructured":"Wieder T, Essmann F, Prokop A, Schmelz K, Schulze-Osthoff K, Beyaert R, D\u00f6rken B, Daniel PT . Activation of caspase-8 in drug-induced apoptosis of B-lymphoid cells is independent of CD95\/Fas receptor ligand interaction and occurs downstream of caspase-3 Blood 2001 97: 1378\u20131387","journal-title":"Blood"},{"key":"BF2402169_CR94","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.1038\/sj.onc.1203824","volume":"19","author":"IH Engels","year":"2000","unstructured":"Engels IH, Stepczynska A, Stroh C, Lauber K, Berg C, Schwenzer R, Wajant H, Janicke RU, Porter AG, Belka C, Gregor M, Schulze-Osthoff K, Wesselborg S . Caspase-8\/FLICE functions as an executioner caspase in anticancer drug-induced apoptosis Oncogene 2000 19: 4563\u20134573","journal-title":"Oncogene"},{"key":"BF2402169_CR95","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/sj.cdd.4400689","volume":"7","author":"EA Slee","year":"2000","unstructured":"Slee EA, Keogh SA, Martin SJ . Cleavage of BID during cytotoxic drug and UV radiation-induced apoptosis occurs downstream of the point of Bcl-2 action and is catalysed by caspase-3: a potential feedback loop for amplification of apoptosis-associated mitochondrial cytochrome c release Cell Death Differ 2000 7: 556\u2013565","journal-title":"Cell Death Differ"},{"key":"BF2402169_CR96","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/sj.leu.2401716","volume":"14","author":"E Okuma","year":"2000","unstructured":"Okuma E, Saeki K, Shimura M, Ishizaka Y, Yasugi E, Yuo A . Induction of apoptosis in human hematopoietic U937 cells by granulocyte\u2013macrophage colony-stimulating factor: possible existence of caspase 3-like pathway Leukemia 2000 14: 612\u2013619","journal-title":"Leukemia"},{"key":"BF2402169_CR97","doi-asserted-by":"crossref","first-page":"10057","DOI":"10.1073\/pnas.94.19.10057","volume":"94","author":"ZL Chu","year":"1997","unstructured":"Chu ZL, McKinsey TA, Liu L, Gentry JJ, Malim MH, Ballard DW . Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control Proc Natl Acad Sci USA 1997 94: 10057\u201310062","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF2402169_CR98","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1126\/science.274.5288.787","volume":"274","author":"DJ Antwerp","year":"1996","unstructured":"Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM . Suppression of TNF-\u03b1-induced apoptosis by NF-\u03baB Science 1996 274: 787\u2013789","journal-title":"Science"},{"key":"BF2402169_CR99","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1126\/science.281.5383.1680","volume":"281","author":"CY Wang","year":"1998","unstructured":"Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS Jr . NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation Science 1998 281: 1680\u20131683","journal-title":"Science"},{"key":"BF2402169_CR100","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/0092-8674(95)90149-3","volume":"83","author":"M Rothe","year":"1995","unstructured":"Rothe M, Pan MG, Henzel WJ, Ayres TM, Goeddel DV . The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins Cell 1995 83: 1243\u20131252","journal-title":"Cell"},{"key":"BF2402169_CR101","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1126\/science.7544915","volume":"269","author":"M Rothe","year":"1995","unstructured":"Rothe M, Sarma V, Dixit VM, Goeddel DV . TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40 Science 1995 269: 1424\u20131427","journal-title":"Science"},{"key":"BF2402169_CR102","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1093\/emboj\/17.8.2215","volume":"17","author":"QL Deveraux","year":"1998","unstructured":"Deveraux QL, Roy N, Stennicke HR, Van Arsdale T, Zhou Q, Srinivasula SM, Alnemri ES, Salvesen GS, Reed JC . IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases EMBO J 1998 17: 2215\u20132223","journal-title":"EMBO J"},{"key":"BF2402169_CR103","doi-asserted-by":"crossref","first-page":"6914","DOI":"10.1093\/emboj\/16.23.6914","volume":"16","author":"N Roy","year":"1997","unstructured":"Roy N, Deveraux QL, Takahashi R, Salvesen GS, Reed JC . The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases EMBO J 1997 16: 6914\u20136925","journal-title":"EMBO J"},{"key":"BF2402169_CR104","doi-asserted-by":"crossref","first-page":"18099","DOI":"10.1074\/jbc.M908925199","volume":"275","author":"PJ Duriez","year":"2000","unstructured":"Duriez PJ, Wong F, Dorovini-Zis K, Shahidi R, Karsan A . A1 functions at the mitochondria to delay endothelial apoptosis in response to tumor necrosis factor J Biol Chem 2000 275: 18099\u201318107","journal-title":"J Biol Chem"},{"key":"BF2402169_CR105","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/00002371-199110000-00010","volume":"10","author":"TD Brown","year":"1991","unstructured":"Brown TD, Goodman P, Fleming T, Macdonald JS, Hersh EM, Braun TJ . A phase II trial of recombinant tumor necrosis factor in patients with adenocarcinoma of the pancreas: a Southwest Oncology Group study J Immunother 1991 10: 376\u2013378","journal-title":"J Immunother"},{"key":"BF2402169_CR106","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/1097-0142(19900815)66:4<659::AID-CNCR2820660410>3.0.CO;2-2","volume":"66","author":"N Kemeny","year":"1990","unstructured":"Kemeny N, Childs B, Larchian W, Rosado K, Kelsen D . A phase II trial of recombinant tumor necrosis factor in patients with advanced colorectal carcinoma Cancer 1990 66: 659\u2013663","journal-title":"Cancer"},{"key":"BF2402169_CR107","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/78475","volume":"18","author":"H Zhang","year":"2000","unstructured":"Zhang H, Cook J, Nickel J, Yu R, Stecker K, Myers K, Dean NM . Reduction of liver Fas expression by an antisense oligonucleotide protects mice from fulminant hepatitis Nat Biotechnol 2000 18: 862\u2013867","journal-title":"Nat Biotechnol"},{"key":"BF2402169_CR108","doi-asserted-by":"crossref","first-page":"5624","DOI":"10.4049\/jimmunol.152.12.5624","volume":"152","author":"PT Daniel","year":"1994","unstructured":"Daniel PT, Krammer PH . Activation induces sensitivity toward APO-1 (CD95)-mediated apoptosis in human B cells J Immunol 1994 152: 5624\u20135632","journal-title":"J Immunol"},{"key":"BF2402169_CR109","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/eji.1830270433","volume":"27","author":"PT Daniel","year":"1997","unstructured":"Daniel PT, Oettinger U, Mapara MY, Bommert K, Bargou R, D\u00f6rken B . Activation and activation-induced death of human tonsillar B cells and Burkitt lymphoma cells: lack of CD95 (Fas\/APO-1) ligand expression and function Eur J Immunol 1997 27: 1029\u20131034","journal-title":"Eur J Immunol"},{"key":"BF2402169_CR110","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/373438a0","volume":"373","author":"J Dhein","year":"1995","unstructured":"Dhein J, Walczak H, Baumler C, Debatin KM, Krammer PH . Autocrine T-cell suicide mediated by APO-1\/(Fas\/CD95) Nature 1995 373: 438\u2013441","journal-title":"Nature"},{"key":"BF2402169_CR111","doi-asserted-by":"crossref","first-page":"5746","DOI":"10.4049\/jimmunol.154.11.5746","volume":"154","author":"C Lagresle","year":"1995","unstructured":"Lagresle C, Bella C, Daniel PT, Krammer PH, Defrance T . Regulation of germinal center B cell differentiation. Role of the human APO-1\/Fas (CD95) molecule J Immunol 1995 154: 5746\u20135756","journal-title":"J Immunol"},{"key":"BF2402169_CR112","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.4049\/jimmunol.159.8.3808","volume":"159","author":"PT Daniel","year":"1997","unstructured":"Daniel PT, Kroidl A, Cayeux S, Bargou R, Blankenstein T, D\u00f6rken B . Costimulatory signals through B7.1\/CD28 prevent T cell apoptosis during target cell lysis J Immunol 1997 159: 3808\u20133815","journal-title":"J Immunol"},{"key":"BF2402169_CR113","doi-asserted-by":"crossref","first-page":"4750","DOI":"10.1182\/blood.V92.12.4750","volume":"92","author":"PT Daniel","year":"1998","unstructured":"Daniel PT, Kroidl A, Kopp J, Sturm I, Moldenhauer G, D\u00f6rken B, Pezzutto A . Immunotherapy of B-cell lymphoma with CD3x19 bispecific antibodies: costimulation via CD28 prevents \u2018veto\u2019 apoptosis of antibody-targeted cytotoxic T cells Blood 1998 92: 4750\u20134757","journal-title":"Blood"},{"key":"BF2402169_CR114","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/S0301-472X(99)00079-X","volume":"27","author":"PT Daniel","year":"1999","unstructured":"Daniel PT, Scholz C, Essmann F, Westermann J, Pezzutto A, D\u00f6rken B . CD95\/Fas-triggered apoptosis of activated T lymphocytes is prevented by dendritic cells through a CD58-dependent mechanism Exp Hematol 1999 27: 1402\u20131408","journal-title":"Exp Hematol"},{"key":"BF2402169_CR115","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nm0198-021","volume":"4","author":"A Strasser","year":"1998","unstructured":"Strasser A, O'Connor L . Fas ligand \u2013 caught between Scylla and Charybdis Nat Med 1998 4: 21\u201322","journal-title":"Nat Med"},{"key":"BF2402169_CR116","first-page":"793","volume":"15","author":"B Bonavida","year":"1999","unstructured":"Bonavida B, Ng CP, Jazirehi A, Schiller G, Mizutani Y . Selectivity of TRAIL-mediated apoptosis of cancer cells and synergy with drugs: the trail to non-toxic cancer therapeutics Int J Oncol 1999 15: 793\u2013802","journal-title":"Int J Oncol"},{"key":"BF2402169_CR117","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/74972","volume":"6","author":"S Nagata","year":"2000","unstructured":"Nagata S . Steering anti-cancer drugs away from the TRAIL Nat Med 2000 6: 502\u2013503","journal-title":"Nat Med"},{"key":"BF2402169_CR118","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/75045","volume":"6","author":"M Jo","year":"2000","unstructured":"Jo M, Kim TH, Seol DW, Esplen JE, Dorko K, Billiar TR, Strom SC . Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand Nat Med 2000 6: 564\u2013567","journal-title":"Nat Med"},{"key":"BF2402169_CR119","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0140-6736(00)02659-3","volume":"356","author":"R Nitsch","year":"2000","unstructured":"Nitsch R, Bechmann I, Deisz RA, Haas D, Lehmann TN, Wendling U, Zipp F . Human brain-cell death induced by tumour-necrosis-factor-related apoptosis-inducing ligand (TRAIL) Lancet 2000 356: 827\u2013828","journal-title":"Lancet"},{"key":"BF2402169_CR120","first-page":"3716","volume":"95","author":"L Zamai","year":"2000","unstructured":"Zamai L, Secchiero P, Pierpaoli S, Bassini A, Papa S, Alnemri ES, Guidotti L, Vitale M, Zauli G . TNF-related apoptosis-inducing ligand (TRAIL) as a negative regulator of normal human erythropoiesis Blood 2000 95: 3716\u20133724","journal-title":"Blood"},{"key":"BF2402169_CR121","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1038\/sj.leu.2401501","volume":"13","author":"Y Gazitt","year":"1999","unstructured":"Gazitt Y . TRAIL is a potent inducer of apoptosis in myeloma cells derived from multiple myeloma patients and is not cytotoxic to hematopoietic stem cells Leukemia 1999 13: 1817\u20131824","journal-title":"Leukemia"},{"key":"BF2402169_CR122","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1182\/blood.V91.10.3943","volume":"91","author":"C Beltinger","year":"1998","unstructured":"Beltinger C, Kurz E, Bohler T, Schrappe M, Ludwig WD, Debatin KM . CD95 (APO-1\/Fas) mutations in childhood T-lineage acute lymphoblastic leukemia Blood 1998 91: 3943\u20133951","journal-title":"Blood"},{"key":"BF2402169_CR123","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1182\/blood.V91.10.3935","volume":"91","author":"S Tamiya","year":"1998","unstructured":"Tamiya S, Etoh K, Suzushima H, Takatsuki K, Matsuoka M . Mutation of CD95 (Fas\/Apo-1) gene in adult T-cell leukemia cells Blood 1998 91: 3935\u20133942","journal-title":"Blood"},{"key":"BF2402169_CR124","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/75007","volume":"6","author":"T Teitz","year":"2000","unstructured":"Teitz T, Wei T, Valentine MB, Vanin EF, Grenet J, Valentine VA, Behm FG, Look AT, Lahti JM, Kidd VJ . Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN Nat Med 2000 6: 529\u2013535","journal-title":"Nat Med"},{"key":"BF2402169_CR125","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/sj.leu.2401776","volume":"14","author":"KH Shain","year":"2000","unstructured":"Shain KH, Landowski TH, Buyuksal I, Cantor AB, Dalton WS . Clonal variability in CD95 expression is the major determinant in Fas-medicated, but not chemotherapy-medicated apoptosis in the RPMI 8226 multiple myeloma cell line Leukemia 2000 14: 830\u2013840","journal-title":"Leukemia"},{"key":"BF2402169_CR126","first-page":"917","volume":"16","author":"N Ozoren","year":"2000","unstructured":"Ozoren N, Fisher MJ, Kim K, Liu CX, Genin A, Shifman Y, Dicker DT, Spinner NB, Lisitsyn NA, El-Deiry WS . Homozygous deletion of the death receptor DR4 gene in a nasopharyngeal cancer cell line is associated with TRAIL resistance Int J Oncol 2000 16: 917\u2013925","journal-title":"Int J Oncol"},{"key":"BF2402169_CR127","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1038\/sj.leu.2401954","volume":"14","author":"M Irisarri","year":"2000","unstructured":"Irisarri M, Plumas J, Bonnefoix T, Jacob M, Roucard C, Pasquier M, Sotto J, Lajmanovich A . Resistance to CD95-mediated apoptosis through constitutive c-FLIP expression in a non-Hodgkin's lymphoma B cell line Leukemia 2000 14: 2149\u20132158","journal-title":"Leukemia"},{"key":"BF2402169_CR128","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1038\/sj.leu.2400815","volume":"11","author":"L Xerri","year":"1997","unstructured":"Xerri L, Devilard E, Bouabdallah R, Hassoun J, Chaperot L, Birg F, Plumas J . Quantitative analysis detects ubiquitous expression of apoptotic regulators in B cell non-Hodgkin's lymphomas Leukemia 1997 11: 1868\u20131877","journal-title":"Leukemia"},{"key":"BF2402169_CR129","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/sj.leu.2401866","volume":"14","author":"A Prokop","year":"2000","unstructured":"Prokop A, Wieder T, Sturm I, Essmann F, Seeger K, Wuchter C, Ludwig W-D, Henze G, D\u00f6rken B, Daniel PT . Relapse in childhood acute lymphoblastic leukemia is associated with decrease of Bax\/Bcl-2-ratio and loss of spontaneous caspase-3 processing in vivo Leukemia 2000 14: 1606\u20131613","journal-title":"Leukemia"},{"key":"BF2402169_CR130","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/35022514","volume":"406","author":"J Chai","year":"2000","unstructured":"Chai J, Du C, Wu JW, Kyin S, Wang X, Shi Y . Structural and biochemical basis of apoptotic activation by Smac\/DIABLO Nature 2000 406: 855\u2013862","journal-title":"Nature"},{"key":"BF2402169_CR131","doi-asserted-by":"crossref","first-page":"36152","DOI":"10.1074\/jbc.C000533200","volume":"275","author":"SM Srinivasula","year":"2000","unstructured":"Srinivasula SM, Datta P, Fan XJ, Fernandes-Alnemri T, Huang Z, Alnemri ES . Molecular determinants of the caspase-promoting activity of Smac\/DIABLO and its role in the death receptor pathway J Biol Chem 2000 275: 36152\u201336157","journal-title":"J Biol Chem"},{"key":"BF2402169_CR132","first-page":"3051","volume":"60","author":"H Walczak","year":"2000","unstructured":"Walczak H, Bouchon A, Stahl H, Krammer PH . Tumor necrosis factor-related apoptosis-inducing ligand retains its apoptosis-inducing capacity on Bcl-2- or Bcl-xL-overexpressing chemotherapy-resistant tumor cells Cancer Res 2000 60: 3051\u20133057","journal-title":"Cancer Res"},{"key":"BF2402169_CR133","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/jcp.1041300304","volume":"130","author":"Z Darzynkiewicz","year":"1987","unstructured":"Darzynkiewicz Z, Carter SP, Old LJ . Effect of recombinant tumor necrosis factor on HL-60 cells: cell-cycle specificity and synergism with actinomycin D J Cell Physiol 1987 130: 328\u2013335","journal-title":"J Cell Physiol"},{"key":"BF2402169_CR134","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1172\/JCI116010","volume":"90","author":"S Isonishi","year":"1992","unstructured":"Isonishi S, Jekunen AP, Hom DK, Eastman A, Edelstein PS, Thiebaut FB, Christen RD, Howell SB . Modulation of cisplatin sensitivity and growth rate of an ovarian carcinoma cell line by bombesin and tumor necrosis factor-alpha J Clin Invest 1992 90: 1436\u20131442","journal-title":"J Clin Invest"},{"key":"BF2402169_CR135","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/jnci\/89.11.783","volume":"89","author":"O Micheau","year":"1997","unstructured":"Micheau O, Solary E, Hammann A, Martin F, Dimanche-Boitrel MT . Sensitization of cancer cells treated with cytotoxic drugs to fas-mediated cytotoxicity J Natl Cancer Inst 1997 89: 783\u2013789","journal-title":"J Natl Cancer Inst"},{"key":"BF2402169_CR136","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/sj.leu.2401327","volume":"13","author":"C Posovszky","year":"1999","unstructured":"Posovszky C, Friesen C, Herr I, Debatin KM . Chemotherapeutic drugs sensitize pre-B ALL cells for CD95- and cytotoxic T-lymphocyte-mediated apoptosis Leukemia 1999 13: 400\u2013409","journal-title":"Leukemia"},{"key":"BF2402169_CR137","first-page":"6153","volume":"59","author":"B Gliniak","year":"1999","unstructured":"Gliniak B, Le T . Tumor necrosis factor-related apoptosis-inducing ligand's antitumor activity in vivo is enhanced by the chemotherapeutic agent CPT-11 Cancer Res 1999 59: 6153\u20136158","journal-title":"Cancer Res"},{"key":"BF2402169_CR138","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1128\/MCB.15.6.3032","volume":"15","author":"LB Owen-Schaub","year":"1995","unstructured":"Owen-Schaub LB, Zhang W, Cusack JC, Angelo LS, Santee SM, Fujiwara T, Roth JA, Deisseroth AB, Zhang WW, Kruzel E . Wild-type human p53 and a temperature-sensitive mutant induce Fas\/APO-1 expression Mol Cell Biol 1995 15: 3032\u20133040","journal-title":"Mol Cell Biol"},{"key":"BF2402169_CR139","doi-asserted-by":"crossref","first-page":"6411","DOI":"10.1038\/sj.onc.1203025","volume":"18","author":"GS Wu","year":"1999","unstructured":"Wu GS, Burns TF, McDonald ER, 3rd, Meng RD, Kao G, Muschel R, Yen T, el-Deiry WS . Induction of the TRAIL receptor KILLER\/DR5 in p53-dependent apoptosis but not growth arrest Oncogene 1999 18: 6411\u20136418","journal-title":"Oncogene"},{"key":"BF2402169_CR140","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1006\/mthe.2000.0025","volume":"1","author":"RD Meng","year":"2000","unstructured":"Meng RD, McDonald ER, 3rd, Sheikh MS, Fornace AJ Jr, El-Deiry WS . The TRAIL decoy receptor TRUNDD (DcR2, TRAIL-R4) is induced by adenovirus-p53 overexpression and can delay TRAIL-, p53-, and KILLER\/DR5-dependent colon cancer apoptosis Mol Ther 2000 1: 130\u2013144","journal-title":"Mol Ther"},{"key":"BF2402169_CR141","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1038\/sj.leu.2401865","volume":"14","author":"MS Sheikh","year":"2000","unstructured":"Sheikh MS, Fornace AJ Jr . Death and decoy receptors and p53-mediated apoptosis Leukemia 2000 14: 1509\u20131513","journal-title":"Leukemia"},{"key":"BF2402169_CR142","first-page":"143","volume":"465","author":"GS Wu","year":"2000","unstructured":"Wu GS, Kim K, el-Deiry WS . KILLER\/DR5, a novel DNA-damage inducible death receptor gene, links the p53-tumor suppressor to caspase activation and apoptotic death Adv Exp Med Biol 2000 465: 143\u2013151","journal-title":"Adv Exp Med Biol"},{"key":"BF2402169_CR143","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1038\/sj.leu.2401901","volume":"14","author":"K Gronbaek","year":"2000","unstructured":"Gronbaek K, de Nully Brown P, Moller M, Nedergaard T, Ralfkiaer E, Moller P, Zeuthen J, Guldberg P . Concurrent disruption of p16INK4a and the ARF-p53 pathway predicts poor prognosis in aggressive non-Hodgkin's lymphoma Leukemia 2000 14: 1727\u20131735","journal-title":"Leukemia"},{"key":"BF2402169_CR144","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/sj.leu.2401619","volume":"14","author":"M Zhou","year":"2000","unstructured":"Zhou M, Gu L, Abshire T, Homans A, Billett A, Yeager A, Findley H . Incidence and prognostic significance of MDM2 oncoprotein overexpression in relapsed childhood acute lymphoblastic leukemia Leukemia 2000 14: 61\u201367","journal-title":"Leukemia"},{"key":"BF2402169_CR145","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1038\/sj.leu.2401198","volume":"12","author":"M Zhou","year":"1998","unstructured":"Zhou M, Gu L, Yeager AM, Findley HW . Sensitivity to Fas-mediated apoptosis in pediatric acute lymphoblastic leukemia is associated with a mutant p53 phenotype and absence of Bcl-2 expression Leukemia 1998 12: 1756\u20131763","journal-title":"Leukemia"},{"key":"BF2402169_CR146","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/sj.leu.2401280","volume":"13","author":"HW Findley","year":"1999","unstructured":"Findley HW, Zhou M . The clinical significance of Fas expression in leukemia: questions and controversies Leukemia 1999 13: 147\u2013149","journal-title":"Leukemia"},{"key":"BF2402169_CR147","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1038\/sj.leu.2401333","volume":"13","author":"C Friesen","year":"1999","unstructured":"Friesen C, Fulda S, Debatin KM . Cytotoxic drugs and the CD95 pathway Leukemia 1999 13: 1854\u20131858","journal-title":"Leukemia"},{"key":"BF2402169_CR148","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/sj.leu.2401902","volume":"14","author":"E Solary","year":"2000","unstructured":"Solary E, Droin N, Bettaieb A, Corcos L, Dimanche-Boitrel MT, Garrido C . Positive and negative regulation of apoptotic pathways by cytotoxic agents in hematological malignancies Leukemia 2000 14: 1833\u20131849","journal-title":"Leukemia"},{"key":"BF2402169_CR149","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/sj.onc.1203401","volume":"19","author":"C Belka","year":"2000","unstructured":"Belka C, Rudner J, Wesselborg S, Stepczynska A, Marini P, Lepple-Wienhues A, Faltin H, Bamberg M, Budach W, Schulze-Osthoff K . Differential role of caspase-8 and BID activation during radiation- and CD95-induced apoptosis Oncogene 2000 19: 1181\u20131190","journal-title":"Oncogene"},{"key":"BF2402169_CR150","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1182\/blood.V90.3.935","volume":"90","author":"CM Eischen","year":"1997","unstructured":"Eischen CM, Kottke TJ, Martins LM, Basi GS, Tung JS, Earnshaw WC, Leibson PJ, Kaufmann SH . Comparison of apoptosis in wild-type and Fas-resistant cells: chemotherapy-induced apoptosis is not dependent on Fas\/Fas ligand interactions Blood 1997 90: 935\u2013943","journal-title":"Blood"},{"key":"BF2402169_CR151","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1084\/jem.191.1.195","volume":"191","author":"K Newton","year":"2000","unstructured":"Newton K, Strasser A . Ionizing radiation and chemotherapeutic drugs induce apoptosis in lymphocytes in the absence of Fas or FADD\/MORT1 signaling. Implications for cancer therapy J Exp Med 2000 191: 195\u2013200","journal-title":"J Exp Med"},{"key":"BF2402169_CR152","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1182\/blood.V93.9.3053","volume":"93","author":"S Wesselborg","year":"1999","unstructured":"Wesselborg S, Engels IH, Rossmann E, Los M, Schulze-Osthoff K . Anticancer drugs induce caspase-8\/FLICE activation and apoptosis in the absence of CD95 receptor\/ligand interaction Blood 1999 93: 3053\u20133063","journal-title":"Blood"},{"key":"BF2402169_CR153","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1038\/sj.leu.2401900","volume":"14","author":"K Kitamura","year":"2000","unstructured":"Kitamura K, Minami Y, Yamamoto K, Akao Y, Kiyoi H, Saito H, Naoe T . Involvement of CD95-independent caspase-8 activation in arsenic trioxide-induced apoptosis Leukemia 2000 14: 1743\u20131750","journal-title":"Leukemia"},{"key":"BF2402169_CR154","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/sj.leu.2401649","volume":"14","author":"Y Nomura","year":"2000","unstructured":"Nomura Y, Inanami O, Takahashi K, Matsuda A, Kuwabara M . 2-Chloro-2\u2032-deoxyadenosine induces apoptosis through the Fas\/Fas ligand pathway in human leukemia cell line MOLT-4 Leukemia 2000 14: 299\u2013306","journal-title":"Leukemia"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2402169.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2402169","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2402169.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T17:19:56Z","timestamp":1682356796000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2402169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,7,1]]},"references-count":154,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2001,7,1]]}},"alternative-id":["BF2402169"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2402169","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,7,1]]},"assertion":[{"value":"19 January 2001","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2001","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2001","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}